Please use this identifier to cite or link to this item: https://doi.org/10.1002/jgm.1522
DC FieldValue
dc.titleAntiglioma effects of combined use of a baculovirual vector expressing wild-type p53 and sodium butyrate
dc.contributor.authorGuo, H.
dc.contributor.authorChoudhury, Y.
dc.contributor.authorYang, J.
dc.contributor.authorChen, C.
dc.contributor.authorTay, F.C.
dc.contributor.authorLim, T.M.
dc.contributor.authorWang, S.
dc.date.accessioned2014-10-27T08:21:59Z
dc.date.available2014-10-27T08:21:59Z
dc.date.issued2011-01
dc.identifier.citationGuo, H., Choudhury, Y., Yang, J., Chen, C., Tay, F.C., Lim, T.M., Wang, S. (2011-01). Antiglioma effects of combined use of a baculovirual vector expressing wild-type p53 and sodium butyrate. Journal of Gene Medicine 13 (1) : 26-36. ScholarBank@NUS Repository. https://doi.org/10.1002/jgm.1522
dc.identifier.issn1099498X
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/100098
dc.description.abstractBackground: Combination therapy is usually desirable for successful cancer treatment, especially in cancers that are resistant to single forms of therapy. +Methods: To achieve an optimal therapeutic effect against glioblastoma, we tested a strategy that combines baculovirus-mediated transfer of the p53 tumor suppressor gene with the use of sodium butyrate, a histone deacetylase inhibitor. This strategy was designed based on the findings that the transduction efficiency of baculovirus in mammalian cells can be markedly enhanced by the addition of histone deacetylase inhibitors and that these inhibitors are effective in inducing cell cycle arrest, differentiation, or apoptosis in tumor cells. +Results: We observed a synergistic effect of the combination of the two treatments in provoking apoptosis in glioblastoma cells with mutant p53. In a mouse glioma xenograft model, the tumor inhibitory effect of baculovirus-expressed p53 was significantly enhanced by co-administration of sodium butyrate. +Conclusions: These findings suggest a new approach to treat glioblastoma using baculovirus-mediated gene transfer in combination with administration of histone deacetylase inhibitor. © 2010 John Wiley & Sons, Ltd.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1002/jgm.1522
dc.sourceScopus
dc.subjectBaculovirus
dc.subjectCombination therapy
dc.subjectGlioblastoma
dc.subjectHistone deacetylase inhibitor
dc.subjectP53 tumor suppressor
dc.typeArticle
dc.contributor.departmentBIOLOGICAL SCIENCES
dc.description.doi10.1002/jgm.1522
dc.description.sourcetitleJournal of Gene Medicine
dc.description.volume13
dc.description.issue1
dc.description.page26-36
dc.description.codenJGMEF
dc.identifier.isiut000287161100003
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

10
checked on Jul 19, 2019

WEB OF SCIENCETM
Citations

7
checked on Jul 19, 2019

Page view(s)

38
checked on Jul 20, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.